{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T01:50:41Z","timestamp":1792288241249,"version":"4.4.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jsat.2021.108385","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T12:45:28Z","timestamp":1617885928000},"page":"108385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Research on substance use disorders during the COVID-19 pandemic"],"prefix":"10.1016","volume":"129","author":[{"given":"Nora D.","family":"Volkow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jsat.2021.108385_bb0005","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/jamapsychiatry.2020.3177","article-title":"Opportunities for research on the treatment of substance use disorders in the context of COVID-19","volume":"78","author":"Blanco","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"10182","key":"10.1016\/j.jsat.2021.108385_bb0010","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(18)33078-2","article-title":"Management of opioid use disorder in the USA: Present status and future directions","volume":"393","author":"Blanco","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jsat.2021.108385_bb0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41398-020-0847-1","article-title":"America\u2019s opioid crisis: The need for an integrated public health approach","volume":"10","author":"Blanco","year":"2020","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.jsat.2021.108385_bb0020","first-page":"1","article-title":"The expanding digital divide: Digital health access inequities during the COVID-19 pandemic in New York City","author":"Eruchalu","year":"2021","journal-title":"J Urban Health"},{"key":"10.1016\/j.jsat.2021.108385_bb0025","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/s41591-020-1001-6","article-title":"A stochastic agent-based model of the SARS-CoV-2 epidemic in France","author":"Hoertel","year":"2020","journal-title":"Nat Med."},{"key":"10.1016\/j.jsat.2021.108385_bb0030","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMsb1900856","article-title":"Creating a learning health system through rapid-cycle, randomized testing","volume":"381","author":"Horwitz","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jsat.2021.108385_bb0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.34878","article-title":"Racial\/ethnic disparities in unintentional fatal and nonfatal emergency medical services-attended opioid overdoses during the COVID-19 pandemic in Philadelphia","volume":"4","author":"Khatri","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jsat.2021.108385_bb0040","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2020.1225","article-title":"Psychiatry in times of the coronavirus disease 2019 (COVID-19) pandemic: An imperative for psychiatrists to act now","author":"Luykx","year":"2020","journal-title":"JAMA Psychiatry."},{"key":"10.1016\/j.jsat.2021.108385_bb0045","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.chc.2016.06.005","article-title":"Technology-based interventions for preventing and treating substance use among youth","volume":"25","author":"Marsch","year":"2016","journal-title":"Child and Adolescent Psychiatric Clinics of North America"},{"issue":"1","key":"10.1016\/j.jsat.2021.108385_bb0050","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13722-019-0135-7","article-title":"Study protocol for a pragmatic trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) model for engaging patients in opioid use disorder treatment","volume":"14","author":"McNeely","year":"2019","journal-title":"Addict Sci Clin Pract"},{"key":"10.1016\/j.jsat.2021.108385_bb0055","article-title":"The impact of survey mode on US national estimates of adolescent drug prevalence: Results from a randomized controlled study","author":"Miech","year":"2020","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.jsat.2021.108385_bb2005","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/jamainternmed.2020.8710","article-title":"The COVID-19 pandemic-an opportune time to update medical licensing","volume":"181","author":"Mullangi","year":"2021","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.jsat.2021.108385_bb0060","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.18513","article-title":"Fairly prioritizing groups for access to COVID-19 vaccines","author":"Persad","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jsat.2021.108385_bb0065","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.idc.2020.06.004","article-title":"Infective endocarditis in persons who use drugs: Epidemiology, current management, and emerging treatments","volume":"34","author":"Schranz","year":"2020","journal-title":"Infectious Disease Clinics of North America"},{"key":"10.1016\/j.jsat.2021.108385_bb0070","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/jama.2020.15589","article-title":"Ethical considerations for COVID-19 vaccine trials in correctional facilities","volume":"324","author":"Wang","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jsat.2021.108385_bb0075","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41380-020-00880-7","article-title":"COVID-19 risk and outcomes in patients with substance use disorders: Analyses from electronic health records in the United States","volume":"26","author":"Wang","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jsat.2021.108385_bb0080","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1001\/jama.2020.8598","article-title":"COVID-19 and racial\/ethnic disparities","volume":"323","author":"Webb Hooper","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jsat.2021.108385_bb0085","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.genhosppsych.2020.09.004","article-title":"Disparities in outpatient visits for mental health and\/or substance use disorders during the COVID surge and partial reopening in Massachusetts","volume":"67","author":"Yang","year":"2020","journal-title":"General Hospital Psychiatry"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221001112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221001112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:54:20Z","timestamp":1760039660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547221001112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":18,"alternative-id":["S0740547221001112"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108385","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research on substance use disorders during the COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108385"}}